Wave Life Sciences
100 hedge funds and large institutions have $795M invested in Wave Life Sciences in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 48 increasing their positions, 20 reducing their positions, and 27 closing their positions.
140% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 20
60% more call options, than puts
Call options by funds: $5.24M | Put options by funds: $3.27M
2.92% more ownership
Funds ownership: 85.99% → 88.91% (+2.9%)
9% less funds holding
Funds holding: 110 → 100 (-10)
26% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 27
30% less capital invested
Capital invested by funds: $1.14B → $795M (-$347M)
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$69.7M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$42.5M |
| 3 |
Goldman Sachs
New York
|
+$13.9M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$13.2M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$9.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$35.1M |
| 2 |
RI
RTW Investments
New York
|
-$17M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$15.1M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$11.7M |
| 5 |
AG
Artal Group
Luxembourg
|
-$9.71M |
WVE Hedge Fund Activity: Q2 2019 in Review
100 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q2 2019, worth a combined $795M — down 30% from $1.14B a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of WVE and 20 opened new positions — a net loss of 7 holders — while 20 trimmed existing stakes and 48 added.
The largest buyer was Wellington Management Group, adding an estimated $69.7M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $35.1M sold.
- 100 institutional investors held Wave Life Sciences (WVE) as of Q2 2019, down from 110 in Q1 2019.
- Funds reported $795M of Wave Life Sciences stock for Q2 2019, down 30% quarter-over-quarter.
- 20 funds opened new Wave Life Sciences positions in Q2 2019 and 27 closed out, a net change of -7 holders.
- The largest Wave Life Sciences buyer in Q2 2019 was Wellington Management Group, an estimated $69.7M added.
- The largest Wave Life Sciences seller in Q2 2019 was PFM Health Sciences, an estimated $35.1M sold.
Based on aggregated 13F filings for Q2 2019.